Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

FDA grants Breakthrough Therapy designation to EYLEA Injection for treatment of diabetic retinopathy

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted EYLEA (aflibercept) Injection Breakthrough Therapy designation for the treatment of diabetic retinopathy in patients with diabetic macular edema (DME).

16 Sep 2014

Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer

Eli Lilly and Company today announced that the RAISE trial, a Phase III study of ramucirumab (CYRAMZA) in combination with chemotherapy in patients with metastatic colorectal cancer (mCRC), met its primary endpoint of overall survival.

15 Sep 2014

Research roundup: Prevention services for seniors; drug shortages

This policy brief reports the findings of a systematic review conducted by the Community Health Innovations in Prevention for Seniors (CHIPS) project. ... Clinical preventive services such as colorectal cancer screening and pneumococcal immunization can help reduce rates of premature death and disability. Yet, many older adults are not receiving the full set of clinical preventive services that have been proven effective and are considered "high value" in terms of their costs per life saved. Rates are particularly low among racial and ethnic minority older adults compared to national goals.

15 Sep 2014

USPSTF lung cancer screening recommendations in high-risk Medicare beneficiaries is cost effective

Questions regarding effectiveness, infrastructure and cost effectiveness of low-dose computed tomography (CT) screening of those at high risk for lung cancer have now been answered. Medicare should rapidly provide full national coverage for these exams.

3 Sep 2014

XBiotech reports interim results from Phase III study for anti-cancer agent Xilonix

XBiotech announced today interim results from its fast-tracked Phase III study being conducted in the US for its anti-cancer agent Xilonix.

2 Sep 2014

Research roundup: Benefits of hip surgery; preventing surgical infections; assessing ACOs' predecessors

Surgical treatment of hip fractures can achieve better survival and functional outcomes than nonoperative treatment, but less is known about its economic benefits. ... We estimated the effects of surgical treatment for displaced hip fractures through a Markov cohort analysis of patients 65 years and older. ... Estimated average lifetime societal benefits per patient exceeded the direct medical costs of hip fracture surgery by $65,000 to $68,000 for displaced hip fractures. With the exception of the assumption of nursing home use, the sensitivity analyses show that surgery produces positive net societal savings (Gu, Koenig, Mather and Tongue, 8/5).

30 Aug 2014

Solid-head power toothbrushes retain less bacteria than hollow-head toothbrushes

Solid-head power toothbrushes retain less bacteria compared to hollow-head toothbrushes, according to researchers at The University of Texas Health Science Center at Houston School of Dentistry.

29 Aug 2014

Colorectal cancer therapies market to remain constant at $7.7 billion by 2023

Decision Resources Group finds that the market for colorectal cancer (CRC) therapies will remain constant, at around $7.7 billion by 2023 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

28 Aug 2014

Patients with intestinal polyps have lower risk of dying from cancer

Patients with intestinal polyps have a lower risk of dying from cancer than previously thought, according to Norwegian researchers.

28 Aug 2014

Three pilot programs aim to improve colorectal cancer screening, follow-up care in community setting

Three locations will each receive $100,000 in funding to launch pilot programs to improve colorectal cancer screening rates and follow-up care for patients served by community health centers. The program is the work of the National Colorectal Cancer Roundtable and is part of the group's effort to reach the goal of 80 percent of adults 50 and over receiving regular screening for colorectal cancer by 2018.

28 Aug 2014

Cancer can be changed from terminal to chronic by cutting liver piece by piece

New surgical methods give hope to patients with cancer that has spread from the intestine to the liver. The disease can be changed from terminal to chronic by cutting the liver piece by piece using keyhole surgery.

25 Aug 2014

Findings may help policy makers address barriers to access to care

A recent study has found that in states with higher Medicaid payments for office visits, Medicaid beneficiaries were more likely to be screened for breast, cervical, and colorectal cancer.

25 Aug 2014

Sanofi, Regeneron present alirocumab Phase 3 trial results at ESC Congress 2014

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that details from four pivotal trials in the alirocumab ODYSSEY clinical program will be presented on Sunday, August 31, during a Hot Line session at ESC Congress 2014 in Barcelona, Spain, the world's largest cardiology meeting.

25 Aug 2014

Health insurance reimbursement may determine cancer screening rates

A study published today indicates that people living in American states that offer higher Medicaid payments for office visits are more likely to have been screened for breast, cervical, and colorectal cancers than those in states giving lower levels of Medicaid support.

25 Aug 2014

Study finds a host of new clues on gene-environment interactions in Crohn's disease

A new study finds a wide range of epigenetic changes-alterations in DNA across the genome that may be related to key environmental exposures-in children with Crohn's disease (CD), reports Inflammatory Bowel Diseases, official journal of the Crohn's & Colitis Foundation of America.

23 Aug 2014

Study shows new role for protein APC in suppressing colorectal cancer

A study recently published in the journal Carcinogenesis by researchers at the University of Kansas shows a new role for the protein adenomatous polyposis coli (APC) in suppressing colorectal cancer - the second-leading cause of cancer-related deaths in the U.S.

22 Aug 2014

Research roundup: Benefits of smaller practices; Rx price growth; fixing Medicare claims reviews

The Centers for Medicare & Medicaid Services within the Department of Health and Human Services has taken steps to prevent its contractors from conducting certain duplicative postpayment claims reviews - reviews of the same claims that are not permitted by the agency - but CMS neither has reliable data nor provides sufficient oversight and guidance to measure and fully prevent duplication.

16 Aug 2014

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

FDA grants Breakthrough Therapy designation to EYLEA Injection for treatment of diabetic retinopathy

Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer

Research roundup: Prevention services for seniors; drug shortages

USPSTF lung cancer screening recommendations in high-risk Medicare beneficiaries is cost effective

XBiotech reports interim results from Phase III study for anti-cancer agent Xilonix

Research roundup: Benefits of hip surgery; preventing surgical infections; assessing ACOs' predecessors

Solid-head power toothbrushes retain less bacteria than hollow-head toothbrushes

Colorectal cancer therapies market to remain constant at $7.7 billion by 2023

Patients with intestinal polyps have lower risk of dying from cancer

Three pilot programs aim to improve colorectal cancer screening, follow-up care in community setting

Cancer can be changed from terminal to chronic by cutting liver piece by piece

Findings may help policy makers address barriers to access to care

Sanofi, Regeneron present alirocumab Phase 3 trial results at ESC Congress 2014

Health insurance reimbursement may determine cancer screening rates

Study finds a host of new clues on gene-environment interactions in Crohn's disease

Study shows new role for protein APC in suppressing colorectal cancer

Research roundup: Benefits of smaller practices; Rx price growth; fixing Medicare claims reviews

VolitionRx installs automated liquid handling system to increase rate of blood sample analysis

Screening with flexible sigmoidoscopy results in reduced incidence, death rate of colorectal cancer

Screening test for colon cancer wins FDA approval

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Newsletters you may be interested in